STANDARD BIOTOOLS INC. — Form 8-K
Filed November 19, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Standard BioTools stockholders approved the merger with Treeline Biosciences and concurrent sale of the Mass Cytometry business to GMT Venture Partners' Element Biosystems at a special meeting on November 19, 2026. The Treeline merger is expected to close in Q4 2026. No specific financial terms or stake percentages are disclosed in this announcement, only the approval of the transactions and two new equity plans (Post-Closing Equity Incentive Plan and Employee Stock Purchase Plan).
Why this rating
Major M&A with business restructuring—sale of one division and merger with another substantially alters company's trajectory and operations. Relative to $291M market cap, this transformational event is material.
Tradability signal
NO TRADE
No trade: the filing reads positive but the market is selling it (-4.8% since it hit EDGAR) — when our read and the tape disagree this hard, we stand aside. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
before filing · preread $0.64 ▲ 4.23% | at our read · unknown $0.61 | +10 min · unknown $0.61 ▼ 0.28% | +30 min · unknown $0.59 ▼ 3.42% | +1 hr · unknown $0.62 ▲ 0.67% | +4 hrs · unknown $0.60 ▼ 2.02% |
The stock had already moved -4.06% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.